Patients How the rise of medical device use in pharma R&D is driving ... As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand.
Digital Digital measures and pre-competitive collaborations Digital measures from a patient’s home and known environments offer greater health insights.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
